36556 Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices 

(indicating one or more false-positive 

test results in Phase 1). 

The follow-up schedule will consist 

of up to nine visits scheduled at regular 

intervals over a 70-day period. At each 

follow-up visit, participants will be 

tested with the new HIV tests and 

additional oral fluid and blood 

specimens will also be collected for 

storage and use in future HIV test 

evaluations at CDC. Participants will be 

followed only to the point at which all 

their test results become concordant. At 

each time point, participants will be 

asked to complete the Phase 2 HIV 

Symptom and Care survey to collect 

information on symptoms associated 

with early HIV infection as well as 

access to HIV care and treatment since 

the last Phase 2 visit. When all tests 

become concordant (i.e., at the last 

Phase 2 visit) participants will complete 

the Phase 2 Behavioral Survey to 

identify any behavioral changes during 

follow-up. Of the 50 Phase 2 

participants; it is estimated that no more 

than 26, annually, will have early HIV 

infection. 

All data for the proposed information 

collection will be collected via an 

electronic Computer Assisted SelfInterview (CASI) survey. Participants 

will complete the surveys on an 

encrypted computer, with the exception 

of the Phase 2 Symptom and Care 

survey, which will be administered by 

a research assistant and then 

electronically entered into the CASI 

system. Data to be collected via CASI 

include questions on sociodemographic 

characteristics, medical care, HIV 

testing, pre-exposure prophylaxis, 

antiretroviral treatment, sexually 

transmitted diseases (STD) history, 

symptoms of early HIV infection, 

substance use and sexual behavior. 

Data from the surveys will be merged 

with HIV test results and relevant 

clinical data using the unique 

identification (ID) number. Data will be 

stored on a secure server managed by 

the awardee’s Information Technology 

(IT) Services. The participation of 

respondents is voluntary. There is no 

cost to the respondents other than their 

time. The total estimated annual burden 

hours for the proposed project are 1,594 

hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Persons eligible for 

study.

Phase 1 Consent ................................................. 2,334 1 15/60 584 

Enrolled participants ...... Phase 1 Enrollment Survey ................................. 1,867 1 30/60 934 

Phase 2 Consent ................................................. 50 1 15/60 13 

Phase 2 HIV Symptom and Care survey ............ 50 9 5/60 38 

Phase 2 Behavioral Survey ................................. 50 1 30/60 25 

Total ........................ .............................................................................. ........................ ........................ ........................ 1,594 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–14754 Filed 7–9–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30 Day–21–1242] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Strengthening 

U.S. Response to Resistant Gonorrhea 

(SURRG) to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on 

September 30, 2020 to obtain comments 

from the public and affected agencies. 

CDC received one non-substantive 

comment related to the previous notice. 

This notice serves to allow an additional 

30 days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Strengthening U.S. Response to 

Resistant Gonorrhea (SURRG) (OMB 

Control No. 0920–1242, Exp. 9/30/ 

2021)—Revision—National Center for 

HIV/AIDS, Viral Hepatitis, STD, and TB 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices 36557 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The purposes of Strengthening U.S. 

Response to Resistant Gonorrhea 

(SURRG) are to: (1) Improve national 

capacity to detect, monitor, and respond 

to the emerging threat of antibioticresistant gonorrhea, (2) understand 

trends in and factors contributing to 

antibiotic-resistant gonorrhea, and (3) 

build a robust evidence-base for public 

health action. This information 

collection is important because: (1) 

Effective treatment of gonorrhea is 

critical to gonorrhea control and 

prevention, (2) untreated or 

inadequately treated gonorrhea can 

cause serious reproductive health 

complications, such as infertility, (3) 

Neisseria gonorrhoeae (the bacterium 

that causes gonorrhea) has consistently 

demonstrated the ability to develop 

resistance to the antibiotics used for 

treatment and may be developing 

resistance to the last remaining 

treatment option recommended by the 

Centers for Disease Control and 

Prevention (CDC), and (4) antibioticresistant gonorrhea is extremely difficult 

to detect without enhanced surveillance 

and public health activities, such as 

SURRG, because healthcare providers 

rarely perform or have access to 

resistance testing for individual 

patients. 

SURRG supports rapid detection of 

resistant gonorrhea and gets actionable 

information into the hands of healthcare 

providers (to support appropriate 

treatment of individual patients) and 

local health departments (to support 

rapid public health response to slow the 

spread of resistant infections in the 

community). Jurisdictions participating 

in SURRG applied as part of a 

competitive process and participate 

voluntarily. As an overview of SURRG, 

healthcare providers at participating 

clinics (sexually transmitted disease 

[STD] clinics affiliated with a single 

public health department or other 

participating non-STD clinic sites) 

collect specimens for N. gonorrhoeae 

culture testing from men and women 

seeking care for possible gonorrhea. 

Specimens that demonstrate N. 

gonorrhoeae (called ‘‘isolates’’) undergo 

antibiotic resistance testing within 

several days at a local public health 

laboratory. Laboratory results 

demonstrating resistance are rapidly 

communicated by the laboratory staff to 

the healthcare provider and designated 

health department staff member, who 

initiates a field investigation. The 

patient (from whom the resistant 

specimen was collected) is interviewed 

about risk factors and recent contacts, 

and will be re-tested to ensure that they 

were cured. Recent contacts are 

interviewed by the health department 

(contact tracing) and tested for 

gonorrhea. The participating health 

departments collect and transmit to CDC 

demographic and clinical data about 

persons tested for, and diagnosed with 

gonorrhea in the participating clinics, 

results of local antibiotic resistance 

testing, and information about field 

investigations. None of the data 

transmitted to CDC contains any 

personally identifiable information. 

These data are used by CDC to 

monitor resistance, understand risk 

factors for resistance, and identify the 

most effective approaches to prevent the 

spread of resistance. Data are 

transmitted through CDC’s Secure 

Access Management Services (SAMS). 

SAMS is an approved federal 

information technology system that 

provides authorized and validated users 

secure and encrypted access to CDC file 

transfer applications. The encrypted 

data are stored in a secure CDC server 

with strictly controlled and restricted 

access rights. Isolates are shipped each 

month to one of four Antibiotic 

Resistance Regional Laboratory Network 

(ARLN) laboratories for confirmatory 

antibiotic susceptibility testing and 

molecular characterization. The isolates 

only contain bacterial DNA (and not 

human DNA). 

Under the SURRG protocol, the local 

SURRG data managers from each of the 

funded jurisdictions abstract STD clinic 

data for patients tested for gonorrhea, 

receive data from non-STD clinic 

healthcare sites about persons tested for 

gonorrhea, receive resistance testing 

laboratory results from local public 

health laboratories, abstract data about 

field investigations, and merge the data. 

Every two months, the local SURRG 

data manager cleans the data, removes 

personally identifiable information, and 

transmits the data to CDC. We estimate 

these data processes will take 16 hours 

every two months. Annually, the local 

SURRG data manager will send a final 

cumulative data file, so a total of seven 

data transmissions/responses will occur. 

Every two months, data managers at 

each of the participating non-STD clinic 

health centers abstract and clean data 

and securely transmits the data to the 

local SURRG data manager. We estimate 

that it will take three hours each time 

data managers at each non-STD SURRG 

location abstract, clean, and transmit 

SURRG data. 

Microbiologists at public health 

laboratories from each of the eight 

SURRG funded jurisdictions conduct 

antibiotic resistance testing on all N. 

gonorrhoeae isolates from all STD clinic 

sites and non-STD clinic sites 

participating in SURRG. Each test takes 

approximately 10 minutes of staff time, 

and testing of control strains is also 

conducted approximately twice per 

week at each laboratory. On average, 

each jurisdiction conducts 

approximately 600 resistance tests per 

year for patient care, plus 100 control 

strains per year for quality assurance. 

Thus, a total of approximately 700 tests 

per year per grantee are performed. 

Every two months, a laboratory data 

manager abstracts test results and 

securely sends the datafile to the local 

SURRG data manager. We estimate that 

laboratory data managers spend 

approximately one hour each time they 

abstract, clean, and transmit project 

data. 

Health department staff will 

interview: Any person diagnosed with 

antibiotic-resistant gonorrhea or have a 

case of gonorrhea of public health 

significance index case, and their sexual 

contacts. On average, each jurisdiction 

will identify four drug-resistant isolates 

each month. These isolates will spur 

field investigations, which will result in 

six additional interviews each month. 

We estimate a total of 120 interviews 

will occur annually at each site, for a 

total across the 8 sites of 960 interviews 

each year. Each interview will take 

approximately 20 minutes. 

The total estimated annual burden 

hours are 2,665. There are no additional 

costs to respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Local SURRG data manager .......................... Facility Data Elements ................................... 8 7 16 


khammond on DSKJM1Z7X2PROD with NOTICES
36558 Federal Register / Vol. 86, No. 130 / Monday, July 12, 2021 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Data manager at non-STD clinic health centers.Non-STD clinic Data Elements ...................... 26 6 3 

Public Health Laboratory Microbiologist ......... Laboratory Testing Data Elements ................ 8 700 10/60 

Public Health Laboratory Data Manager ........ Laboratory Data Elements ............................. 8 6 1 

Gonorrhea Patients and Sexual Contacts ...... Field Investigation Data Elements ................. 960 1 20/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–14751 Filed 7–9–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[CFDA Number: 93.676] 

Announcement of Intent To Issue One 

Operating Division (OPDIV)-Initiated 

Supplement to BCFS Health and 

Human Services Under the Standing 

Announcement for Residential 

(Shelter) Services for Unaccompanied 

Alien Children, HHS–2017–ACF–ORR– 

ZU–1132 

AGENCY: Unaccompanied Alien 

Children’s (UAC) Program, Office of 

Refugee Resettlement (ORR), 

Administration for Children and 

Families (ACF), Department of Health 

and Human Services (HHS). 

ACTION: Notice of intent to issue one 

OPDIV-Initiated Supplement to BCFS 

Health and Human Services (BCFS 

HHS), San Antonio, Texas under the 

UAC Program. 

SUMMARY: ACF, ORR, announces the 

issuance of one OPDIV-Initiated 

Supplement to BCFS HHS, San Antonio, 

Texas in the amount of up to 

$475,868,102. ORR has been identifying 

additional capacity to provide shelter 

for potential increases in apprehensions 

of UAC at the Southwest Border. 

Planning for increased shelter capacity 

is a prudent step to ensure that ORR is 

able to meet its responsibility, by law, 

to provide shelter for UAC referred to its 

care by the Department of Homeland 

Security. To ensure sufficient capacity 

to provide shelter to UAC referred to 

HHS, ORR is requesting that BCFS HHS 

continue the use of up to 1008 hardsided beds at Carrizo Springs, Texas. 

DATES: Supplemental award funds will 

support activities until January 31, 

2022. 

FOR FURTHER INFORMATION CONTACT: 

Stephen Antkowiak, Office of Refugee 

Resettlement, Division of 

Unaccompanied Alien Children 

Operations, 330 Street SW, Washington, 

DC 20447. Phone: 202–260–6165. Email: 

stephen.antkowiak@acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: ORR is 

continuously monitoring its capacity to 

shelter the UAC referred to HHS, as well 

as the information received from 

interagency partners, to inform any 

future decisions or actions. 

ORR has specific requirements for the 

provision of services. Award recipients 

must have the infrastructure, licensing, 

experience, and appropriate level of 

trained staff to meet those requirements. 

The expansion of the existing program 

and its services through this 

supplemental award is a key strategy for 

ORR to be prepared to meet its 

responsibility to provide shelter for 

UAC referred to its care by the 

Department of Homeland Security 

(DHS), and so the Customs and Border 

Protection can continue its vital 

national security mission to prevent 

illegal migration, trafficking, and protect 

the borders of the United States. 

Statutory Authority: This program is 

authorized by— 

(A) Section 462 of the Homeland 

Security Act of 2002, which in March 

2003, transferred responsibility for the 

care and custody of UAC from the 

Commissioner of the former 

Immigration and Naturalization Service 

to the Director of ORR within HHS. 

(B) The Flores Settlement Agreement, 

Case No. CV85–4544–RJK (C.D. Cal. 

1996), as well as the William 

Wilberforce Trafficking Victims 

Protection Reauthorization Act of 2008 

(Pub. L. 110–457), which authorizes 

post release services under certain 

conditions to eligible children. All 

programs must comply with the Flores 

Settlement Agreement, Case No. CV85– 

4544–RJK (C.D. Cal. 1996); pertinent 

regulations; and ORR policies and 

procedures. 

Elizabeth Leo, 

Senior Grants Policy Specialist, Office of 

Grants Policy, Office of Administration. 

[FR Doc. 2021–14722 Filed 7–7–21; 4:15 pm] 

BILLING CODE 4184–45–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

[OMB# 0985–New] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Evidence Based 

Program Fidelity Surveys 

AGENCY: Administration for Community 

Living, HHS. 

ACTION: Notice. 

SUMMARY: The Administration for 

Community Living (ACL) is announcing 

an opportunity for the public to 

comment on the proposed collection of 

information listed above. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish a notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the information collection requirements 

relating to a Grantee Survey and a Local 

Implementation Organization Survey 

that will be used by ACL to evaluate the 

fidelity with which ACL and its grantee 

organizations, under the Older 

Americans Act, implement the required 

evidence-based programs. 

DATES: Comments on the collection of 

information must be submitted 

electronically by 11:59 p.m. (EST) or 

postmarked by September 10, 2021. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to: Susan.Jenkins@

acl.hhs.gov. Submit written comments 

on the collection of information to 


khammond on DSKJM1Z7X2PROD with NOTICES